Lung cancer screening infrastructure for every stakeholder
We build the AI and the network. You bring the mission, the patients, or the funding. Five ways organizations work with us to close the lung screening gap.
From community health centers to pharmaceutical companies, our platform adapts to your screening goals.
Find every eligible patient in your panel
LungIQ identifies screening eligible patients from clinical notes, no EHR integration required. Works from a CSV or flat file export. Tracks outreach, scheduling, and HEDIS completion automatically.
- No EHR integration required, works from CSV export
- HEDIS and quality metric tracking built in
- Consortium model connects FQHCs to imaging partners
AI assisted reads and referred scan volume
LungAI provides a 0 to 100 malignancy probability score for every nodule, delivered inside your existing CADe viewer. The consortium model drives referred scan volume from community health centers in your region.
- LungAI scores inside your existing CADe workflow
- Referred LDCT volume from FQHC consortium
- CPT 0721T reimbursement pathway following FDA clearance. LungAI is investigational and not FDA 510(k) cleared.
Turn grant funding into measurable screening completions
Embed LungIQ directly into your community health partners. Every dollar spent on screening is tracked from patient identification through completed LDCT, giving you the outcomes data grant compliance requires.
- Outcomes reporting for grant compliance and renewals
- Proven reach into Black, Hispanic, and rural communities
- No technology burden on your grantee sites
Population level screening across FQHC networks
State and local health departments deploy LungIQ across FQHC networks to drive lung cancer screening rates for Medicaid and underinsured populations. Population level dashboards track screening completion by region, demographics, and site.
- Population level dashboards and screening rate reporting
- HIPAA compliant data infrastructure, BAA ready
- Proven model for Medicaid and underinsured populations
34M+ patients across a nationwide FQHC network
Access diverse, underserved patient populations for clinical trial enrollment, real world evidence studies, and representative study populations. Our FQHC network spans community health centers across the country with verified demographic data.
- 34M+ patients across diverse, underserved communities
- Clinical trial enrollment and real world evidence data
- Demographic reporting for study sponsors
Ready to close the lung cancer screening gap?
Whether you are a community health center, imaging center, nonprofit, public health agency, or life sciences company, we have a program built for you.
Get started